Comparison

Ketamine vs MAOIs

MAOIs are powerful older antidepressants effective for atypical and treatment-resistant depression. They require strict dietary and drug interaction discipline. Ketamine offers comparable response without dietary restrictions.

Written by: Ira ZootMedical review status: Not yet clinically reviewed.Last updated: June 4, 2026Evidence: Educational synthesis - not medical advice

This page has been written and edited by the publisher. It has not been reviewed by a licensed clinician.

Quick answer

Bottom line

Ketamine bypasses MAOI dietary restrictions but doesn't replicate sustained monoamine effects. For some patients, MAOIs after ketamine non-response remain a meaningful option.

This page compares Ketamine and MAOIs across the same fixed dimensions - mechanism, evidence, onset, duration, side effects, access, suitability, and limits. It does not name a winner and does not recommend either option for you.

Related on Ketalux

Ketamine

MAOIs

Mechanism

NMDA antagonism with glutamatergic and neuroplastic downstream effects.

Inhibition of monoamine oxidase, raising serotonin, norepinephrine, and dopamine.

Evidence

Strong rapid-onset evidence in TRD.

Well-established for atypical depression and TRD; less commonly prescribed today.

Onset

Hours to days.

Two to six weeks.

Duration

Requires maintenance dosing or integration.

Ongoing while taken as prescribed.

Side effects

Transient dissociation, blood pressure, nausea.

Hypertensive crisis with tyramine-rich foods, insomnia, orthostatic hypotension, weight gain.

Access

Specialty clinics.

Psychiatry-prescribed; pharmacy-stocked but uncommon.

Best for

Patients seeking rapid relief without daily medication or dietary restriction.

Atypical depression; treatment-resistant patients willing to manage dietary restrictions.

Limits

Cost, access, requires repeat sessions.

Dietary and drug-interaction burden; slower onset.

Disclaimer

This comparison is educational and general. It is not a recommendation. Treatment choice depends on your individual history, diagnosis, prior response, preferences, and access - discuss with a qualified clinician.

About the author

Ira Zoot

Publisher and editor of Ketalux, based in Chicago, Illinois. Ira is a ketamine therapy patient, not a clinician. This is editorial review, not medical review: Ira is not a licensed clinician and does not provide diagnosis or medical care. Ketalux does not accept compensation from providers in exchange for favorable editorial coverage, evidence ratings, recommendations, patient referrals, or organic provider ranking. Read the full publisher disclosure →

Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.